

US stocks traded lower on Friday as technology shares fell. The NASDAQ 100 dropped 1.9%. The S&P 500 declined 1.3% after a record close on Thursday. The Dow Jones Industrial Average dropped a little, about 0.6%.
Broadcom stock drove much of the early weakness, falling over 10%. The chipmaker fell after it issued a sales outlook that missed high expectations for AI demand. The drop also pressured other AI-linked shares. Investors shifted some funds into small caps and value stocks, which helped steady parts of the market.
Global equities also eased. The MSCI World Index fell 0.4% and the Stoxx Europe 600 slipped 0.1%. The Russell 2000 fell 0.5% as traders assessed the outlook for domestic growth. Investors watched breadth across sectors closely.
Treasury yields rose as traders weighed the path for interest rates. The 30-year Treasury yield climbed 4 basis points to about 4.84%. The 10-year yield added 2 basis points to around 4.18%. Higher long yields pressured tech shares.
Federal Reserve officials kept inflation in focus. Cleveland Fed President Beth Hammack said she would prefer policy to stay slightly more restrictive. Chicago Fed President Austan Goolsbee said he dissented against this week’s rate cut and wanted more inflation data. Philadelphia Fed President Anna Paulson said she expects inflation to cool next year, while she noted labor-market risks.
The dollar index held near unchanged after recent weakness. Spot gold rose 0.8% to about $4,313.96 an ounce, while WTI crude fell 0.6% to roughly $57.25 a barrel. Bitcoin slipped 2.5% to about $90,500.
Investors continued to talk about diversification as 2026 approaches. Strong gains in mega-cap growth raised concerns about concentration risk. Some managers increased exposure to sectors that lagged in technology. Others looked outside the US, including parts of Asia and emerging markets.
Goldman Sachs strategists reiterated a longer-term S&P 500 target near 7,600 in 2026. They linked that call to steady growth and broader AI use in business. Several other firms also projected gains of more than 10% for US stocks.
Europe also drew attention as investors looked for wider participation. In a Bloomberg survey of 17 strategists, none expected a major decline in 2026. The median forecast pointed to gains for the Stoxx Europe 600, with some estimates near 13%. Some investors also positioned for a year-end rally and bought laggards.
Broadcom fell after guidance disappointed investors focused on AI demand.
Swiss lawmakers proposed softer capital rules for UBS, pushing the stock to a 17-year high.
Lululemon rallied after it raised its full-year outlook and set a CEO transition plan.
SoftBank explored potential deals, including data center operator Switch, to expand AI infrastructure exposure.
Bristol-Myers Squibb rose after Guggenheim upgraded the stock to buy.
Roblox slid after JPMorgan downgraded the shares to neutral.
NASDAQ filed a rule that would let it reject listings when it spots manipulation risk or governance red flags.
NASDAQ said the change would apply immediately, including to IPOs already under review.
The SEC suspended trading in several Asia-based microcaps since late September over manipulation concerns.
FINRA investigated broker-dealers linked to small foreign IPOs after extreme price swings.
US stocks ended the week on a weaker note as tech-led losses and rising Treasury yields pressured major indexes. With 2026 approaching, markets now look to broader participation and steadier macro signals to guide the next leg higher.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here.